Migraine‐related genes (e.g., CALCA, PRDM16) show a moderate association (OR = 1.85, 95% CI [1.05–3.24]), suggesting a genetic influence on triptan response beyond pain pathways. Here, PRDM16 is linked to migraine disorder.